Questcor Pharmaceuticals (QCOR) Slammed as Cerium Pharmaceuticals Granted FDA Orphan Drug Status
Go back to Questcor Pharmaceuticals (QCOR) Slammed as Cerium Pharmaceuticals Granted FDA Orphan Drug Status| Questcor Pharmacueticals, Inc. (NASDAQ: QCOR) | Delayed: 93.60 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $93.60 | 52 Week High | $97.80 | |||
| Open | $0.00 | 52 Week Low | $58.89 | |||
| Day High | $93.60 | P/E | 21.72 | |||
| Day Low | $93.60 | EPS | $4.31 | |||
| Volume | 67,200 | |||||
